Skip to main content

Boehringer Ingelheim Pharmaceuticals Inc - Industry - BI 655130 in Ulcerative Colitis Subjects

Clinical Trial Grant
Duke Scholars

Awarded By

Boehringer Ingelheim Corporation

Start Date

April 4, 2019

End Date

July 30, 2020
 

Awarded By

Boehringer Ingelheim Corporation

Start Date

April 4, 2019

End Date

July 30, 2020